Results per Page:
Value in Cancer Care Summit reimagines cancer care
Annual conference zeroes in on practical solutions for patient and provider pain points like burnout, symptom management and financial toxicity
Are we ready for multi-cancer detection tests?
Blood-based cancer tests are coming, but questions about efficacy, reimbursement and diagnostic pathways are far from settled
Fred Hutch leads new Vanguard Study for Cancer Screening Research Network
Study aims to understand the effectiveness and use of multi-cancer detection blood tests
Saying goodbye to a community partner and friend
Bridgette Hempstead, founder of Cierra Sisters and staunch health equity research advocate, remembered as a force for underserved patients
10 years in, HICOR’s efforts boost cancer care’s value
Fred Hutch’s Value in Cancer Care Initiative celebrates a decade of data and crucial collaborations between providers, payers and patients
What’s new in breast cancer research? SABCS 2023 takeaways
New drug combos for metastatic patients and a strong focus on toxicities at San Antonio Breast Cancer Symposium
How do we increase equity in cancer care?
HICOR’s Value in Cancer Care Summit brings together stakeholders to discuss barriers, pain points and solutions
A user-friendly toolkit for cancer control planning
From the Ramsey Group, Cancer Epidemiology, Prevention, and Control Research Program, Cancer Consortium
ASCO 2022: Equity, innovation and in-person
Hutch cancer researchers, clinicians share findings on clinical trial eligibility, Medicaid expansion, wearables to track symptoms and more
Patient-reported outcomes predict risk of not taking breast cancer drugs
From the Unger and Ramsey Labs, Cancer Epidemiology, Prevention & Control Program, Cancer Consortium
New studies highlight cancer inequities in hospice care, financial impacts
Analyses shared at ASCO annual meeting show lack of home hospice care for Medicaid patients during COVID-19; quantify financial hardships
What’s new in breast cancer research? San Antonio conference goes hybrid for 2021
Hutch researchers look at overdiagnosis, cardiotoxicity of chemotherapy, cost of a new surveillance method and more
The latest on how COVID-19 affects cancer patients
Hutch researchers share new data on mortality rates and racial disparities in treatment; launch statewide COVID-19 and cancer data repository
Fred Hutch announces new collaboration with Roche leveraging digital technology to help cancer patients undergoing chemotherapy
Project will focus on reducing unplanned emergency department visits through a remote monitoring system
A look at emerging sickle cell disease therapies
Teams at the University of Washington School of Pharmacy and Fred Hutch will model the clinical and economic burden of sickle cell disease and the potential benefits of emerging therapies
New data on cancer disparities in Washington
Health equity, patient voices and patient-engaged research hot topics at Value in Cancer Care Summit
Filling in the gap on prevalence of viral infections
From the Ramsey Group, Public Health Sciences Division
Dr. Veena Shankaran joins leadership of Fred Hutch’s health care economics and policy research institute
She will contribute to strategic planning, scientific priority setting, fundraising and organizational development